Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/26/24 16:07 | 9/24/24 | SANA | Health | BioPrd | Biological Products, (No Diag | Mulligan Richard | WA | D | S.m | -1,196 | 3.99 | 0 | -300 | -10 | 2,698 | D | |||||||||||||||
3/11/24 16:57 | 3/8/24 | SANA | Health | BioPrd | Biological Products, (No Diag | Yang Patrick Y | WA | D | S | -236 | 9.45 | 0 | -25 | -14 | 149 | D | |||||||||||||||
12/18/23 16:51 | 12/15/23 | SANA | Health | BioPrd | Biological Products, (No Diag | Hordo Christian | WA | O | EVP,Chie | S | -300 | 4.00 | 0 | -75 | -8 | 867 | D | ||||||||||||||
6/8/23 19:00 | 6/6/23 | SANA | Health | BioPrd | Biological Products, (No Diag | Flagship Ventures Fund V General Partner LLC | MA | T | S.m | -2,533 | 6.27 | 0 | -404 | -1 | 33,290 | I | |||||||||||||||
5/26/23 20:00 | 5/24/23 | SANA | Health | BioPrd | Biological Products, (No Diag | Flagship Ventures Fund V General Partner LLC | MA | T | S.m | -3,527 | 6.47 | 0 | -545 | -2 | 33,694 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |